Analyst consensus rating
Quest Diagnostics Analyst Rating: none
DGX is rated none by 15 analysts with a $245.87 target. As of 2026-08-23.
Direct answer
Quest Diagnostics's consensus rating is none.
15 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $245.87.
Forecast evidence checked August 23, 2026.
Get free Quest Diagnostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $244.39
- Average price target
- $245.87
- High price target
- $265.00
- Low price target
- $204.00
- Low target gap
- -16.5%
- Target upside
- +0.6%
- High target gap
- +8.4%
- Target range width
- 25%
- Consensus rating
- none
- Analysts
- 15
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Quest Diagnostics?
Quest Diagnostics has a verified none consensus. The same dataset has an average price target of $245.87.
How far are Quest Diagnostics's low and high targets from the recorded price?
The low target implies -16.5%, while the high target implies +8.4%.
How many analysts are included in Quest Diagnostics's consensus?
The verified consensus includes 15 analysts.
How is Quest Diagnostics's target upside or downside calculated?
The average target of $245.87 is divided by the recorded price of $244.39, then one is subtracted to produce +0.6%. This does not guarantee a future return.
When was Quest Diagnostics's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.